| Over a week ago | ||||
JPMorgan analyst David… JPMorgan analyst David Adlington lowered the firm's price target on Fresenius SE to EUR 33.30 from EUR 34.50 and keeps a Neutral rating on the shares. | ||||
HSBC analyst Sezgi… HSBC analyst Sezgi Oezener downgraded Fresenius SE to Hold from Buy with a price target of EUR 39, down from EUR 46, post the Q1 results. With cash flows under pressure, the analyst incorporates a higher discount for Fresenius given the more difficult market environment and thinks the conglomerate discount is "likely to remain stubbornly sticky." | ||||
Credit Suisse analyst… Credit Suisse analyst Christoph Gretler raised the firm's price target on Fresenius SE to EUR 38 from EUR 35 and keeps a Neutral rating on the shares. | ||||
| Over a month ago | ||||
Credit Suisse analyst… Credit Suisse analyst Christoph Gretler lowered the firm's price target on Fresenius SE to EUR 35 from EUR 43 and keeps a Neutral rating on the shares. | ||||
Deutsche Bank analyst… Deutsche Bank analyst Falko Friedrichs lowered the firm's price target on Fresenius SE to EUR 36 from EUR 38 and keeps a Hold rating on the shares. | ||||
Societe Generale analyst… Societe Generale analyst Justin Smith lowered the firm's price target on Fresenius SE to EUR 87 from EUR 94 and keeps a Buy rating on the shares. | |
JPMorgan analyst David… JPMorgan analyst David Adlington lowered the firm's price target on Fresenius SE to EUR 34.50 from EUR 42.30 and keeps a Neutral rating on the shares. |
| Over a quarter ago | ||||
Berenberg analyst Tom… Berenberg analyst Tom Jones raised the firm's price target on Fresenius SE to EUR 60.25 from EUR 55.95 and keeps a Buy rating on the shares. | ||||
Deutsche Bank analyst… Deutsche Bank analyst Falko Friedrichs lowered the firm's price target on Fresenius SE to EUR 38 from EUR 42 and keeps a Hold rating on the shares. | ||||
HSBC analyst Sezgi… HSBC analyst Sezgi Oezener initiated coverage of Fresenius SE with a Buy rating and EUR 54 price target. The analyst believes governance "remains at the heart of the story" following look at its ESG track record. The strategic review of Fresenius "remains the hot topic," Oezener tells investors in a research note. | ||||
